These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [High levels of atrial natriuretic peptide and copeptin and mortality risk]. Rey C; García-Cendón C; Martínez-Camblor P; López-Herce J; Concha-Torre A; Medina A; Vivanco-Allende A; Mayordomo-Colunga J An Pediatr (Barc); 2016 Dec; 85(6):284-290. PubMed ID: 26988235 [TBL] [Abstract][Full Text] [Related]
4. Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS. Frøssing S; Nylander M; Kistorp C; Skouby SO; Faber J Endocr Connect; 2018 Jan; 7(1):115-123. PubMed ID: 29295870 [TBL] [Abstract][Full Text] [Related]
5. Cardiac biomarkers as indicators of right ventricular dysfunction and recovery in chronic thromboembolic pulmonary hypertension patients after balloon pulmonary angioplasty therapy - a cardiac magnetic resonance imaging cohort study. Kriechbaum SD; Vietheer JM; Wiedenroth CB; Rudolph F; Barde M; Wolter JS; Haas M; Fischer-Rasokat U; Weferling M; Rolf A; Hamm CW; Mayer E; Guth S; Keller T; Roller FC; Liebetrau C Pulm Circ; 2021; 11(4):20458940211056500. PubMed ID: 34917333 [TBL] [Abstract][Full Text] [Related]
6. Copeptin and mid-regional pro-atrial natriuretic peptide in women with suspected or confirmed pre-eclampsia: comparison with sFlt-1/PlGF ratio. Neuman RI; van der Meer MMA; Saleh L; van den Berg SAA; van den Meiracker AH; Danser AHJ; Visser W Ultrasound Obstet Gynecol; 2020 Dec; 56(6):872-878. PubMed ID: 31975510 [TBL] [Abstract][Full Text] [Related]
7. Mid-regional pro-atrial natriuretic peptide to predict clinical course in heart failure patients undergoing cardiac resynchronization therapy. Arrigo M; Truong QA; Szymonifka J; Rivas-Lasarte M; Tolppanen H; Sadoune M; Gayat E; Cohen-Solal A; Ruschitzka F; Januzzi JL; Singh JP; Mebazaa A Europace; 2017 Nov; 19(11):1848-1854. PubMed ID: 28096288 [TBL] [Abstract][Full Text] [Related]
8. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea. Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868 [TBL] [Abstract][Full Text] [Related]
9. Mid-regional pro-atrial natriuretic peptide independently predicts short-term mortality in COVID-19. Kaufmann CC; Ahmed A; Kassem M; Freynhofer MK; Jäger B; Aicher G; Equiluz-Bruck S; Spiel AO; Funk GC; Gschwantler M; Fasching P; Wojta J; Huber K Eur J Clin Invest; 2021 May; 51(5):e13531. PubMed ID: 33657664 [TBL] [Abstract][Full Text] [Related]
10. Analysis of Electrocardiographic Criteria of Right Ventricular Hypertrophy in Patients with Chronic Thromboembolic Pulmonary Hypertension before and after Balloon Pulmonary Angioplasty. Ley L; Wiedenroth CB; Ghofrani HA; Hoeltgen R; Bandorski D J Clin Med; 2023 Jun; 12(13):. PubMed ID: 37445229 [TBL] [Abstract][Full Text] [Related]
11. Pregnancy-associated plasma protein A - a new indicator of pulmonary vascular remodeling in chronic thromboembolic pulmonary hypertension? Kriechbaum SD; Rudolph F; Wiedenroth CB; Mielzarek L; Haas M; Guth S; Hamm CW; Mayer E; Liebetrau C; Keller T Respir Res; 2020 Aug; 21(1):204. PubMed ID: 32746916 [TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure. Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002 [TBL] [Abstract][Full Text] [Related]
13. Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea. Shah RV; Truong QA; Gaggin HK; Pfannkuche J; Hartmann O; Januzzi JL Eur Heart J; 2012 Sep; 33(17):2197-205. PubMed ID: 22645194 [TBL] [Abstract][Full Text] [Related]
14. Outcome prediction and temperature dependency of MR-proANP and Copeptin in comatose resuscitated patients. Broessner G; Hasslacher J; Beer R; Lackner P; Lehner GF; Harler U; Schiefecker A; Helbok R; Pfausler B; Hammerer-Lercher A; Joannidis M Resuscitation; 2015 Apr; 89():75-80. PubMed ID: 25619444 [TBL] [Abstract][Full Text] [Related]
15. Comparison of pleural N-terminal pro-B-type natriuretic peptide, midregion pro-atrial natriuretic peptide and mid-region pro-adrenomedullin for the diagnosis of pleural effusions associated with cardiac failure. Porcel JM; Bielsa S; Morales-Rull JL; Civit C; Cao G; Light RW; Esquerda A Respirology; 2013 Apr; 18(3):540-5. PubMed ID: 23278975 [TBL] [Abstract][Full Text] [Related]
16. Associations of cardiac stress biomarkers with incident type 2 diabetes and changes in glucose metabolism: KORA F4/FF4 study. Sujana C; Seissler J; Jordan J; Rathmann W; Koenig W; Roden M; Mansmann U; Herder C; Peters A; Thorand B; Then C Cardiovasc Diabetol; 2020 Oct; 19(1):178. PubMed ID: 33066780 [TBL] [Abstract][Full Text] [Related]